H.R. 1249 and S. 23, America Invests Act - Lobbied to improve provisions related to inequitable conduct and supplemental re-examination. 

S. 27, Preserve Access to Affordable Generics Act - Lobbied to oppose banning patent settlements. S. 319, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs.

Continuing Resolutions - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding biosimilars, the Independent Payment Advisory Board and the Annual Fee.

S. 752, Lung Cancer Mortality Reduction Act - Lobbied for passage of bill to reduce lung cancer mortality.

S. 296 and H.R. 2245, Preserving Access to Life-Savings Medications Act - Lobbied to improve provisions in the drug shortage legislation.

H.R. 1483, Drug Safety Enhancement Act of 2011 - Lobbied to pass meaningful drug safety legisaltion.

NO BILL, Reauthorization of the Prescription Drug User Fee Act - Lobbied for passage of clean PDUFA legislation. S. 668, Health Care Bureaucrats Elimination Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board.

H.R. 452, Medicare Decisions Accountability Act - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board. Bill not yet introduced, The Medicare Home Infusion Therapy Coverage Act - Lobbied for expanded coverage of home infusion therapy.

S. 1454 and H.R. 2969, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for extended coverage of immunosuppresive drugs in Medicare.

H.R. 2190 and S. 1206, Medicare Drug Savings Act of 2011 - Lobbied to oppose extending Medicaid rebates to Medicare Part D. S. 365, Budget Control Act of 2011 - Lobbied to oppose extending Medicaid rebates to Part D.

NO BILL, Agriculture, Rural Development, FDA and Related Agencies Appropriations Act of 2012 - Lobbied against potential amendments to allow for the importation of unsafe prescription drugs.
CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of
BRISTOL-MYERS SQUIBB COMPANY
801 Pennsylvania Ave, NW, Suite 745, WASHINGTON, DC, 20004, US
CHRISTOPHER PERNIE LANE PENRY CHRISTOPHER PERNIE LANE PENRY RONALD MILLER CHRISTOPHER PERNIE LANE PENRY RONALD MILLER CHRISTOPHER PERNIE LANE PENRY RONALD MILLER